Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | S28 - Vascular and Other Non-Alzheimer’s Dementias

Wednesday 04/17/24
01:00 PM - 03:00 PM MDT Add To Calendar
Colorado Convention Center | 702/704/706
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Platform Session
Aging, Dementia, Cognitive, and Behavioral Neurology
 A group of abstracts covering a similar topic will be presented in an eight-minute oral format followed by four minutes of question and answer with the author. 
2.00 CME credits

Program Materials

Event Timeline
01:00 PM - 01:12 PM MDT Abstract 001 - Vortioxetine for the Treatment of Post-COVID-19 Condition: A Randomized Controlled Trial
Angela T.H. Kwan, MSc
01:24 PM - 01:36 PM MDT Abstract 003 - Uncovering Post-stroke Cognitive Impairment: A Retrospective Analysis at the University of Oklahoma Vascular Neurology Service
Jennifer Swinton
01:36 PM - 01:48 PM MDT Abstract 004 - Sodium-glucose Co-transporter 2 Inhibitors Lower the Risk for Dementia in Patients with Type 2 Diabetes Mellitus
Shih-Syuan Wang, MD
01:48 PM - 02:00 PM MDT Abstract 005 - Interim Results on VGL101 from IGNITE: First Interventional Phase 2 Study in Patients with Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)
Zbigniew K. Wszolek, MD, FAAN
02:00 PM - 02:12 PM MDT Abstract 006 - Herpes Zoster Vaccination and Risk of Dementia: A Systematic Review and Meta-analysis
Sangharsha Thapa, MD
02:12 PM - 02:24 PM MDT Abstract 007 - Testing the Myelin Hypothesis of Cognitive Aging: Insights from Advanced MRI and Cognitive Testing
Andrea Mendez Colmenares, MD, PhD
02:24 PM - 02:36 PM MDT Abstract 008 - Tracking Longitudinal Change In Presymptomatic Genetic Prion Disease
Michael D. Geschwind, MD, PhD, FAAN
02:36 PM - 02:48 PM MDT Abstract 009 - Risk Perception and the Genetic Testing Gap in Frontotemporal Degeneration (FTD): FTD Insights Survey Highlights the Need for Comprehensive Genetic Counseling
Shana Dodge, PhD
02:48 PM - 03:00 PM MDT Abstract 010 - Cognitive Phenotypes in Multiple Sclerosis: Mapping the Spectrum of Impairment
Damiano Mistri, MSC
Faculty Disclosures
Irina Skylar-Scott, MD An immediate family member of Dr. Skylar-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 3D Systems. The institution of an immediate family member of Dr. Skylar-Scott has received research support from The Chan Zuckerberg Initiative. An immediate family member of Dr. Skylar-Scott has received intellectual property interests from a discovery or technology relating to health care.
Lealani Mae Acosta, MD, MPH, FAAN Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Biohaven, Roche, NIH.
Shana Dodge, PhD Dr. Dodge has received personal compensation for serving as an employee of The Association for Frontotemporal Degeneration.
Kim Jenny Ms. Jenny has received personal compensation for serving as an employee of Invitae. Ms. Jenny has stock in Invitae. Ms. Jenny has received personal compensation in the range of $100,000-$499,999 for serving as a Clinical Consultation with Invitae.
Carrie Milliard Mrs. Milliard has received personal compensation for serving as an employee of FTD Disorders Registry.
Penny Dacks, PhD Dr. Dacks has received personal compensation for serving as an employee of Association for Frontotemporal Degeneration. Dr. Dacks has received personal compensation for serving as an employee of American Epilepsy Society . The institution of an immediate family member of Dr. Dacks has received research support from NIH .
Angela T.H. Kwan, MSc Miss Kwan has nothing to disclose.
Roger S. McIntyre, MD Dr. McIntyre has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for speaker/consultation fees from Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals,Viatris, Abbvie, Atai Life Sciences. Dr. McIntyre has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for speaker/consultation fees from Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals,Viatris, Abbvie, Atai Life Sciences. Dr. McIntyre has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for speaker/consultation fees from Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals,Viatris, Abbvie, Atai Life Sciences. Dr. McIntyre has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for speaker/consultation fees from Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals,Viatris, Abbvie, Atai Life Sciences. Dr. McIntyre has received research support from research grant support from CIHR/GACD/National Natural Science Foundation of China (NSFC) and the Milken Institute. Dr. McIntyre has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Executive Officer with Braxia Scientific Corp.
Lee Phan Miss Phan has nothing to disclose.
Rodrigo Barbachan Mansur, MD,PhD The institution of Dr. Mansur has received research support from CIHR. The institution of Dr. Mansur has received research support from PSI. The institution of Dr. Mansur has received research support from Baszucki Brain Research Fund.
Joshua Rosenblat, MD Dr. Rosenblat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Braxia.
Ziji Guo Mr. Guo has nothing to disclose.
Gia Han Le Ms. Le has nothing to disclose.
Kayla M. Teopiz Miss Teopiz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Braxia Scientific Corp..
Felicia Ceban, Other Ms. Ceban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brain and Cognition Discovery Foundation.
Julia Bailey Ms. Bailey has received personal compensation for serving as an employee of Brain and Cognition Discovery Foundation.
Ranuk Ramachandra Mr. Ramachandra has nothing to disclose.
Joshua Di Vincenzo Mr. Di Vincenzo has received personal compensation in the range of $0-$499 for serving as a Peer Reviewer with Expert Opinion On Pharmacotherapy.
Sebastian Badulescu, Other Mr. Badulescu has nothing to disclose.
Pawel Drzadzewski, MD Dr. Drzadzewski has received research support from Brain and Cognition Discovery Foundation.
Damiano Mistri, MSC Mr. Mistri has nothing to disclose.
Diana Biondi Mrs. Biondi has nothing to disclose.
Nicolò Tedone, Other Dr. Tedone has nothing to disclose.
Carmen Vizzino Carmen Vizzino has nothing to disclose.
Elisabetta Pagani Elisabetta Pagani has nothing to disclose.
Paolo Preziosa Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Maria Assunta Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi;. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi- Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Sophia Fioramonti-Gorchow Miss Fioramonti-Gorchow has received personal compensation for serving as an employee of Regeneron Pharmaceuticals, Inc.
Judith Meadows, MD Dr. Meadows has received personal compensation for serving as an employee of Regeneron Pharmaceuticals.
Mohamed Hussein Dr. Hussein has received personal compensation for serving as an employee of Regeneron. Dr. Hussein has stock in Regeneron.
SERGIO FAZIO, MD,PhD Dr. FAZIO has received personal compensation for serving as an employee of Regeneron. Dr. FAZIO has stock in Regeneron.
Richard T. George, MD Dr. George has received personal compensation for serving as an employee of Regeneron Pharmaceuticals. Dr. George has stock in Regeneron Pharmaceuticals. Dr. George has stock in AstraZeneca.
Aaron P. Kithcart No disclosure on file
Srihari Gopal, MD Dr. Gopal has received personal compensation for serving as an employee of Regeneron. Dr. Gopal has received personal compensation for serving as an employee of Johnson & Johnson.
David S. Lynch, PhD, MBBS Dr. Lynch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vigil Neuroscience. Dr. Lynch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Lynch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vigil Neuroscience.
Jeffrey Marc Gelfand, MD, MAS, FAAN Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant and Expert, Vaccine Injury Compensation Program with United States Health and Human Services and Department of Justice. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities.
Donald *Use 389302 McLaren No disclosure on file
Andreas Meier, MD Dr. Meier has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Meier has received personal compensation for serving as an employee of Voyager Therapeutics. Dr. Meier has stock in Vigil Neuroscience. Dr. Meier has stock in Voyager Therapeutics.
Zbigniew K. Wszolek, MD, FAAN Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica.
Rajasimhan Rajagovindan, PhD Dr. Rajagovindan has received personal compensation for serving as an employee of Biogen. Dr. Rajagovindan has received personal compensation for serving as an employee of Vigil. Dr. Rajagovindan has stock in Biogen. Dr. Rajagovindan has stock in Vigil .
Rajeev Kumar, MD, FRCPC The institution of Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Teva Pharmaceuticals. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda Therapeutics. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevel Therapeutics. Dr. Kumar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Impel Pharma. Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda Therapeutics. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Research Catalyst, LLC. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for CenExel RMCR. Dr. Kumar has stock in Research Catalyst, LLC. Dr. Kumar has stock in CenExel. The institution of Dr. Kumar has received research support from Supernus. The institution of Dr. Kumar has received research support from Sage Therapeutics. The institution of Dr. Kumar has received research support from Prilenia Therapeutics. The institution of Dr. Kumar has received research support from Roche. The institution of Dr. Kumar has received research support from Triplet Therapeutics. The institution of Dr. Kumar has received research support from CHDI Foundation. The institution of Dr. Kumar has received research support from Neurocrine Biosciences. The institution of Dr. Kumar has received research support from Biovie. The institution of Dr. Kumar has received research support from Neuroderm. The institution of Dr. Kumar has received research support from Sanofi. The institution of Dr. Kumar has received research support from Addex Pharma. The institution of Dr. Kumar has received research support from Integrative Research Laboratories. The institution of Dr. Kumar has received research support from Takeda Pharmaceuticals. The institution of Dr. Kumar has received research support from Neuraly. The institution of Dr. Kumar has received research support from Abbvie. The institution of Dr. Kumar has received research support from Cerevel Therapeutics. The institution of Dr. Kumar has received research support from Transposon Therapeutics. The institution of Dr. Kumar has received research support from Lundbeck. The institution of Dr. Kumar has received research support from Biohaven. The institution of Dr. Kumar has received research support from Revance Therapeutics. The institution of Dr. Kumar has received research support from Impax Laboratories. The institution of Dr. Kumar has received research support from Pharma Two B. The institution of Dr. Kumar has received research support from Enterin. The institution of Dr. Kumar has received research support from CND Life Sciences. The institution of Dr. Kumar has received research support from Neuron23. The institution of Dr. Kumar has received research support from Annexon Biosciences. The institution of Dr. Kumar has received research support from Annovis. The institution of Dr. Kumar has received research support from PTC Therapeutics. The institution of Dr. Kumar has received research support from Uniqure. The institution of Dr. Kumar has received research support from Alexza. The institution of Dr. Kumar has received research support from SparkNeuro. The institution of Dr. Kumar has received research support from Praxis. The institution of Dr. Kumar has received research support from Scion Neurostim. The institution of Dr. Kumar has received research support from Cognition Therapeutics. The institution of Dr. Kumar has received research support from Eli Lilly. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Medical Director with CenExel RMCR. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as a Managing Member with Research Catalyst, LLC.
Andrea Mendez Colmenares, MD, PhD Dr. Mendez Colmenares has nothing to disclose.
Agnieszka Burzynska No disclosure on file
Charles Anderson Dr. Anderson has nothing to disclose.
David B. Arciniegas, MD Dr. Arciniegas has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Psychiatric Association Publishing. The institution of Dr. Arciniegas has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Arciniegas has received research support from Department of Defense/Congressionally Directed Medical Research Program. The institution of Dr. Arciniegas has received research support from National Institute on Aging. The institution of Dr. Arciniegas has received research support from Department of Health, State of New Mexico. Dr. Arciniegas has received publishing royalties from a publication relating to health care.
Vince Calhoun No disclosure on file
Arthur Kramer No disclosure on file
Michael Thomas The institution of Dr. Thomas has received research support from NIH.
Kaigang Li, PhD Dr. Li has nothing to disclose.
In Young Choi, PhD Dr. Choi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Choi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer.
Jongho Lee Prof. Lee has nothing to disclose.
Phil Lee, PhD An immediate family member of Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. An immediate family member of Dr. Lee has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Lee has received research support from NIH.
Michael D. Geschwind, MD, PhD, FAAN Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Guoyu Zhou, MD,PhD Dr. Zhou has nothing to disclose.
Michael Terranova Michael Terranova has nothing to disclose.
Theresa Driscoll Theresa Driscoll has nothing to disclose.
Kendra Benisano, RN Ms. Benisano has nothing to disclose.
Kelly Goodman-O'Leary, NP Mrs. Goodman-O'Leary has nothing to disclose.
Supratik Nandi Mr. Nandi has nothing to disclose.
Stacy Metcalf, PhD Dr. Metcalf has nothing to disclose.
Megan Casey, Other Mrs. Casey has nothing to disclose.
Sven Forner No disclosure on file
Robin Schubert Robin Schubert has received personal compensation for serving as an employee of QuantiMedis.
Ralf Reilmann, MD, FAAN The institution of Dr. Reilmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Reilmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for uniQure. The institution of Dr. Reilmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for WAVE. Dr. Reilmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WAVE. The institution of Dr. Reilmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for IOS-Press. The institution of Dr. Reilmann has received research support from European Union. Dr. Reilmann has a non-compensated relationship as a Executive Committee Member with Huntington Study Group that is relevant to AAN interests or activities. Dr. Reilmann has a non-compensated relationship as a Member of Executive Committee with European Huntington Disease Network that is relevant to AAN interests or activities. Dr. Reilmann has a non-compensated relationship as a Co-Chair Task Force on Huntington Disease with Movement Disorders Socitey that is relevant to AAN interests or activities.
Amy Kuo No disclosure on file
Aili Golubjatnikov, RN,Other Ms. Golubjatnikov has nothing to disclose.
Katherine Wong, MD Dr. Wong has nothing to disclose.
Kolette Cho Ms. Cho has nothing to disclose.
Shih-Syuan Wang, MD Dr. Wang has nothing to disclose.
Steven E. Arnold, MD Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EIP Pharma. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Boyle Shaughnessy Law. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wolf Greenfield. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Bob's Last Marathon.
Alvaro Pascual-Leone, MD, PhD, FAAN Dr. Pascual-Leone has received personal compensation for serving as an employee of Linus Health. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magstim. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroelectrics. Dr. Pascual-Leone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TetraNeuron. Dr. Pascual-Leone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms. Dr. Pascual-Leone has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Linus Health. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Pascual-Leone has stock in TI Solutions. The institution of Dr. Pascual-Leone has received research support from NIH. The institution of Dr. Pascual-Leone has received research support from NSF. The institution of Dr. Pascual-Leone has received research support from Brightfocus Foundation . Dr. Pascual-Leone has received intellectual property interests from a discovery or technology relating to health care. Dr. Pascual-Leone has received publishing royalties from a publication relating to health care.
Kevin Sheng-Kai Ma Dr. MA has nothing to disclose.
Pin-Chia Huang Ms. Huang has nothing to disclose.
Jennifer Swinton Mrs. Swinton has nothing to disclose.
Camila Bonin Pinto, PhD Dr. BONIN PINTO has nothing to disclose.
Ana Luyza Oliveira Santos, MD Dr. Oliveira Santos has nothing to disclose.
Cameron Owens, MS Mr. Owens has nothing to disclose.
Cheyenne Gutierrez, RN Mrs. Gutierrez has nothing to disclose.
Blair Apple Blair Apple has nothing to disclose.
Kate Singleton, RN Ms. Singleton has nothing to disclose.
Zyanna Stuart, RN Mrs. Stuart has nothing to disclose.
Andriy Yabluchanskiy Andriy Yabluchanskiy has nothing to disclose.
Faddi Ghassan M. Saleh Velez, MD Dr. Saleh Velez has nothing to disclose.
Sangharsha Thapa, MD Dr. Thapa has nothing to disclose.
Sangam Shah Dr. Shah has nothing to disclose.
Krishna *Use 397216 Dahal, MBBS Dr. Dahal has nothing to disclose.
Haythum Osama Tayeb, MD No disclosure on file
Omid Mirmosayyeb Omid Mirmosayyeb has nothing to disclose.
Aaron Kithcart Dr. Kithcart has received personal compensation for serving as an employee of Regeneron Pharmaceuticals. Dr. Kithcart has stock in Regeneron Pharmaceuticals.